Table 1 Demographics and baseline characteristics of patients infected with SARS-CoV-2.
From: Immunological and inflammatory profiles in mild and severe cases of COVID-19
|  | Total (n = 41) | Mild (n = 29) | Severe (n = 12) | p value |
|---|---|---|---|---|
Age, years | 39.0 (33.5–50.0) | 37.0 (29.0–44.0) | 50.0 (39.75–85.0) | 0.0072 |
Sex | Â | Â | Â | 0.6308 |
Men | 25 (61%) | 17 (59%) | 8 (67%) | Â |
Women | 16 (39%) | 12 (41%) | 4 (33%) | Â |
OnSet of symptom to hospital admission, days | 5.0 (4.0–9.0) | 5.0 (4.0–7.0) | 10.5 (5.0–12.25) | 0.0064 |
Death | 2 (5%) | 0 | 2 (17%) | 0.0805 |
Exposure to Wuhan | 24 (59%) | 18 (62%) | 6 (50%) | 0.4754 |
Any comorbidity | 10 (24%) | 3 (10%) | 7 (58%) | 0.0011 |
Hypertension | 5 (12%) | 1 (3%) | 4 (33%) | 0.0078 |
Diabetes | 4 (10%) | 2 (7%) | 2 (17%) | 0.3374 |
Malignancy | 1 (1%) | 0 | 1 (8%) | 0.2927 |
Chronic liver disease | 3 (7%) | 1 (3%) | 2 (17%) | 0.2002 |
Fever | 35 (85%) | 25 (86%) | 10 (83%) | 0.8128 |
Highest temperature (°C) |  |  |  | 0.63 |
<37.3 | 6 (15%) | 4 (14%) | 2 (17%) | Â |
37.3–38.0 | 9 (22%) | 7 (24%) | 1 (8%) |  |
38.1–39.0 | 18 (44%) | 12 (41%) | 7 (58%) |  |
>39.0 | 8 (20%) | 6 (21%) | 2 (17%) | Â |
Cough | 27 (66%) | 17 (59%) | 10 (83%) | 0.1289 |
Expectoration | 13 (32%) | 6 (21%) | 7 (58%) | 0.0184 |
Rhinorrhoea | 1 (2%) | 1 (3%) | 0 | >0.9999 |
Myalgia or fatigue | 19 (46%) | 9 (31%) | 10 (83%) | 0.0022 |
Nausea and vomiting | 0 | 0 | 0 | Â |
Sore throat | 7 (17%) | 5 (17%) | 2 (17%) | 0.9645 |
Shortness of breath | 5 (12%) | 1 (3%) | 4 (33%) | 0.0078 |
Chest pain | 1 (2%) | 0 | 1 (8%) | 0.2927 |
Diarrhea | 4 (10%) | 4 (14%) | 0 | 0.1756 |
